rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    MNOV
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      MediciNova (MNOV) Reports Q3 Loss, Misses Revenue Estimates
      Nov 12Yahoo FinanceMNOV
      MediciNova’s MN-001 trial misses primary endpoints in NAFLD
      Oct 12Investing.comMNOV
      MediciNova CEO Provides Shareholder Update
      Oct 12Yahoo FinanceMNOV
      MediciNova to Participate in the Maxim Growth Summit
      Oct 6Yahoo FinanceMNOV
      H.C. Wainwright reiterates Buy on MediciNova stock, $10 target
      Sep 29Investing.comMNOV
      Analysts Are Bullish on Top Healthcare Stocks: Medicinova (MNOV), AbbVie (ABBV)

      Detailed price information for Abbvie Inc (ABBV-N) from The Globe and Mail including charting and trades.

      Sep 29The Globe and MailMNOV
      MediciNova extends office lease to 2030 and agrees to rent increases
      Sep 28Investing.comMNOV
      Why Is MediciNova Stock Tumbling Today? - MediciNova (NASDAQ:MNOV)

      MediciNova reported Phase 2 topline trial results for tipelukast in treating NAFLD and hypertriglyceridemia.

      Sep 28BenzingaMNOV
      MediciNova Shares Fall After Phase 2 Tipelukast Trial Misses Primary Endpoints
      Sep 28Yahoo FinanceMNOV
      Why is MediciNova stock sliding today?
      Sep 28Investing.comMNOV
      MediciNova stock tumbles on mixed Phase 2 NAFLD trial data
      Sep 28Investing.comMNOV
      MediciNova reports mixed phase 2 results for MN-001 drug trial
      Sep 28Investing.comMNOV
      MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

      MN-001 showed statistically significant increases in HDL-C and HDL-P and significant early reduction in triglyceride, a reduction in body weight and a numerical improvement in liver fatLA JOLLA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the topline results from MN-001-NATG-202, a Phase 2 clinical trial evaluating

      Sep 28Yahoo FinanceMNOV
      MediciNova Drug Falls Short on Liver Fat Parameter, Stock Tumbles
      Sep 28Yahoo FinanceMNOV
      MediciNova completes double-blind phase of ALS drug trial
      Sep 24Investing.comMNOV
      MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)

      LA JOLLA, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the completion of the last patient, last visit (LPLV) in the double-blind portion of COMBAT-ALS, a Phase 2b/3 clinical trial evaluating MN-166 (ibudilast) for the treatment of Amyotrophic Lateral Sclerosis (ALS). A total of 234 participants were randomized to tw

      Sep 24Yahoo FinanceMNOV
      Roth/MKM initiates MediciNova stock with buy on ALS drug potential
      Sep 17Investing.comMNOV
      Medicinova at H.C. Wainwright conference: data, not financing, drives case
      Sep 11Investing.comMNOV
      MediciNova to Participate in Two Investor Conferences in September

      LA JOLLA, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces that Yuichi Iwaki, M.D., Ph.D., President and CEO, and David H. Crean, Ph.D., Chief Business Officer, will participate in two investor conferences during September. H.C. Wainwright 28th Annual Global Investment Conference, September 14-16 at the Lotte

      Sep 8Yahoo FinanceMNOV

      This is the newest page. Registered accounts read further back.